BRITISH SOCIETY FOR HAEMATOLOGY

BSH 2020 VIRTUAL

 

9-14 November 2020 Virtual Conference
Close
N. Poster
Poster title
Applicant name
Status
  PO-001 Whole genome profiling of adult B-other acute lymphoblastic leukaemia on the UKALL14 trial Daniel Leongamornlert Received Received
  EP-001 Outcomes following treatment discontinuation in chronic myeloid leukaemia ( CML ): real-world experience from 3 regional UK centres Farooq Wandroo Received Received
  EP-002 Could CD45 have a role in the development of myeloid malignancies? Maryam Ahmed Al Barashdi Received Received
  PO-002 Regulation of Acute Myeloid Leukaemia Maintenance by Wilms Tumour 1 in an Isoform Specific Manner Sandeep Potluri Received Received
  PO-004 Exploration of the variant composition in the genome of pediatric and adult recurrent acute myeloid leukemia Svea Stratmann Received Received
  EP-004 Identification of a new target patient population for ibrutinib treatment. Barbara Guinn Received Received
  EP-005 The clinical significance of FLT3-ITD allele burden in AML; a long-term retrospective single centre study. Alasdair Duguid Received Received
  EP-006 Platelet recovery after the first cycle of DA chemotherapy for AML is an independent predictor of survival Sandra Sookramanien Received Received
  EP-007 Antibody Immunotherapy treatment for adults with B - Acute Lymphoblastic Leukaemia A Real-World Analysis. Tania Dexter Received Received
  EP-008 Inotuzumab ozogamicin vs. blinatumomab for adults with Philadelphia chromosome-negative relapsed/refractory B-cell acute lymphoblastic leukaemia in Scotland: corresponding cost-effectiveness and relative treatment effect. Alexander Smith Received Received
  PO-009 Efficacy of FMS-like Tyrosine Kinase 3 (FLT3) Inhibitors in Patients with Acute Myeloid Leukemia THURA HTUT Received Received
  EP-010 Incidence and management of PEGylated-asparaginase related thrombosis in adults with ALL matthew poynton Received Received
  PO-010 Combination Therapies Targeting Apoptosis pathways in Paediatric AML Ahlam Ali Received Received
  PO-011 Combination therapies targeting DNA Damage signalling as a therapeutic strategy in Acute Myeloid Leukaemia. Laura Monaghan Received Received
  PO-012 Use of next generation sequencing to identify AML with germline predisposition; an essential diagnostic test Alasdair Duguid Received Received
  EP-012 Relapsed Acute Lymphoblastic Leukaemia Diagnosed Using Femoral Head Histology Jennifer Ryan Received Received
  PO-013 Inhibition of Myeloid Cell Leukaemia 1 (MCL1) overcomes Bromodomain and Extra-Terminal (BET) inhibition resistance in Acute Myeloid Leukaemia (AML) cells ELENI LADIKOU Received Received
  EP-013 19 courses of CPX-351 for the treatment of AML Stephen Boyd Received Received
  PO-014 Analysis of Treatment Patterns and Outcomes for Patients With Therapy-related Acute Myeloid Leukaemia and Acute Myeloid Leukaemia With Myelodysplasia-related Changes Diagnosed in England Between 20112016 Using Hospital Episode Statistics Alex Legg Received Received
  EP-014 The role of nutrition in aggressive haematological malignancies a single-centre review of patients receiving intensive chemotherapy Graham McIlroy Received Received
  PO-015 Synergistic inhibition of FLT3-ITD Acute Myeloid Leukaemia cell growth in vitro using combination of FLT3 inhibitor quizartinib and standard chemotherapeutic agent cytarabine (also known as AraC) Salihanur Darici Received Received
  EP-016 The utility of flow cytometry in the diagnosis of acute monocytic and monoblastic leukaemias Ian Devanny Received Received
  POA-017 Genetic and genomic characterisation of older adults with acute lymphoblastic leukemia treated on the UKALL14 and UKALL60 clinical trials Anthony Moorman Received Received
  PO-017 Whose choice is it anyway? A multi-national and multi-stakeholder perspective on shared treatment decision making in older adults with acute myeloid leukaemia Lucy Morgan Received Received
  EP-018 Evaluating Vyxeos use in routine clinical practice; data from the South East Scotland Cancer Network Victoria Campbell Received Received
  PO-018 Findings from the UK NEQAS for Leucocyte Immunophenotyping Haematological Malignancy Bone Marrow Aspirate Assessment programme Alison Whitby Received Received
  EP-019 High Risk Cytogenetic Abnormalities in Acute Myeloid Leukemia-Single Centre Experience Shawana Kamran Received Received
  PO-019 Optimising diagnosis and management of acute chest syndrome in sickle cell disease through a full cycle audit of adherence to the BSH guidelines Jennifer Davies Received Received
  EP-020 Single Hospital Retrospective Review of patients in Treatment Free Remission (TFR) following therapy with Tyrosine Kinase Inhibitors (TKIs) for Chronic Myeloid Leukemia (CML) Sumant Kundu Received Received
  PO-020 Graphical Description of Performance Characteristics of Laboratories and Assays using data from the UK NEQAS for Haematinics Finlay MacKenzie Received Received
  EP-022 Single Centre Experience in Use of Leukapheresis for Management of Leukostasis in High Count Leukaemia. fenella Willis Received Received
  PO-023 On Arterial Blood Gas: how can we reduce avoidable sampling? Aina Pons Received Received
  EP-023 The feasibility and impact of remote teaching for haematology registrars Thomas Erblich Received Received
  EP-024 A Toolkit for Undertaking a Volunteer OOPE/visit to a Low Resource Country Matthew Player Received Received
  PO-024 Guidelines and Chips: Food for thought in supporting trainees. Asha Aggarwal Received Received
  PO-025 CDx report program - assessment of the current reporting practice for haemato-oncology companion diagnostics (CDx) markers in the UK and Ireland Neil Atkey Received Received
  EP-025 A little learning is a dangerous thing how little do we know about when to treat pulmonary embolism? Bernard Maybury Received Received
  PO-026 The Haematology Summit 20142019: evolution of a national medical education programme Nigel Prynn Received Received
  PO-028 Education and Training of Healthcare Scientists in Haematology - fit for the future? Sheila OConnor Received Received
  EP-029 Cardiovascular risk factors and events in a district general haematology population undergoing cytotoxic chemotherapy Jonathan Bennett Received Received
  PO-029 Knowledge, Perception and Opinion of Health Workers on Bone Marrow Transplantation in Public Sector Hospital AISHA MAHESAR Received Received
  PO-030 A different kind of OOPE, volunteering to improve Haematology services in Malawi. Matthew Player Received Received
  EP-031 Updated Audit of the Use of Pegylated Interferon in Patients with Myeloproliferative Neoplasms.Are Patients Maintained on Less Frequent Dosing than Once Weekly? Catherine Loughran Received Received
  PO-031 Haembase: Improving the Quality of a Free Open Access Medical Education Resource Targeted at Haematologists in Training Tom Bull Received Received
  PO-033 Suggestions for the monitoring and follow up of patients with systemic mastocytosis based on a single centre tertiary experience. Matthew Alley Received Received
  PO-035 The Impact of Immune Thrombocytopenia (ITP) on Activities of Daily Living: Findings reported by UK patients and physicians from the ITP World Impact Survey (I-WISh) Tom Bailey Received Received
  PO-036 Prolonged corticosteroid use in newly diagnosed primary immune thrombocytopenia Kieran Burton Received Received
  EP-036 An audit of complications arising in central venous access devices (CVADs) in adult Haematology patients, Chesterfield Royal Hospital Rowena Faulkner Received Received
  EP-037 A case of Refractory Heparin induced thrombocytopenia Nitha Ramachandran Received Received
  PO-037 Patients and Health Care Professionals Perspectives on Treatment Goals in Sickle Cell Disease A UK Perspective: Results From the International Sickle Cell World Assessment Survey (SWAY) Tom Bailey Received Received
  EP-039 Investigating compliance of haematology patients with recommended pneumococcal and influenza vaccines. Hamish Miller Received Received
  PO-040 Final results from the Apixaban Length-Of-Stay Pulmonary Embolism study - Hospital Admissions (ALPHA-PE) Emma Still Received Received
  EP-040 Acute haemolysis in a Glucose-6-Phosphate-Dehydrogenase Deficient patient receiving high-dose Vitamin C therapy for metastatic caecal cancer: a case report Rebecca Sen Received Received
  EP-041 Nucleic Acid Containing Units (NACU); A New Parameter in Haematology Graham Gibbs Received Received
  PO-042 The Differential Diagnosis of Basophilia in Patients Undergoing BCR-ABL Testing Caleb Smith Received Received
  EP-042 The Advent of the Extremely Elderly Clinic: Not If, But When? A District General Hospital Experience Ruby Haji Received Received
  PO-043 Immunological effects of ponatinib therapy in patients with chronic myeloid leukaemia Patrick Harrington Received Received
  EP-043 Pica in women in rural South Africa Tessa Fautz Received Received
  PO-044 When should Haematologists see patients with asymptomatic lymphocytosis? Peter Johnstone Received Received
  EP-045 Rhapsody Alerts - How Effective Are They? A Quality Improvement Project Yasmin Nikookam Received Received
  PO-045 UK Adult Immune Thrombocytopenia (ITP) Pregnancy Registry: Collaborative research to better understand outcomes: the first 24 months. Priyanka Raheja Makhija Received Received
  EP-046 Review of antifungal treatment prescriptions for Haematology inpatients at Nottingham University Hospital Rashmi Chandrashekar Received Received
  PO-047 Refining the erythrocytosis diagnostic pathway: an audit of current practice compared to British Society for Haematology guidelines. Rebekah Williams Received Received
  EP-048 A Quantitative Approach to differentiate haemolysis from dilutional changes in patients with Malaria Fatima Sharif Received Received
  PO-050 Disease progression in patients with essential thrombocythaemia receiving anagrelide within a single institution Nicki Gray Received Received
  PO-052 Stopping IM B12: A Collaborative service development between primary and secondary care Morag Griffin Received Received
  PO-054 Low Haemoglobin A1c (HbA1c) result: lessons learnt in clinical practice Mai Khalifa Received Received
  EP-055 A case of Niemann-Pick disease type C diagnosed on bone marrow biopsy: A rare event Sehreen Jahangir Received Received
  PO-055 Efficacy and Safety of Bosutinib by Age and Modified Charlson Comorbidity Index in Previously Treated Patients With Chronic Myeloid Leukemia: Results From the Phase 4 BYOND Study Emily Balevich Received Received
  PO-056 Patients and Physicians Perceptions of Treatments and Goal Setting in Immune Thrombocytopenia (ITP): Findings reported by UK patients and physicians from the ITP World Impact Survey (I-WISh) Tom Bailey Received Received
  EP-056 Pondering Possibilities: PRES vs PML Amanda Swan Received Received
  PO-059 Abstract Steroid Induced Hyperglycemia and Diabetes on the Haematology Ward: Are we getting it right? Re-audit following Initiation of JBDS-IP Guidelines and Teaching Katharine Lazarus Received Received
  PO-061 Managing Patients with Systemic Mastocytosis with Associated Haematological Neoplasm: UK Single Centre Experience Deepti Radia Received Received
  EP-061 Contemporary Real-world Treatment Patterns of Chronic Lymphocytic Leukaemia (CLL) in England Satoshi Hori Received Received
  EP-062 Utility of FDG-PET CT-directed splenic biopsy in lymphoma diagnosis Jawad Saeed Received Received
  PO-062 Prevalence of latent iron deficiency in early pregnancy in a tertiary care hospital in Sri Lanka Neelakshi De Silva Received Received
  EP-063 The GELOX-radiotherapy sandwich regime is a highly effective outpatient regimen for limited stage Extranodal NK/T cell Lymphoma nasal type with acceptable toxicity Jawad Saeed Received Received
  PO-063 Physician Associate (PA) led Myeloproliferative Neoplasm (MPN) telephone clinics: is this the way forward to a revolutionised service? Mai Khalifa Received Received
  PO-064 Capillary Glucose Monitoring in Haematology Inpatients on Glucocorticoids Vinita Ruparel Received Received
  EP-066 Risk stratifying patients presenting with lymphadenopathy an audit of 2 week wait referrals for suspected haematological malignancy compared to NICE guidance Matthew Cant Received Received
  EP-067 Vaccination Recommendation in Newly Diagnosed Chronic lymphocytic Leukaemia: A Retrospective Audit Ruth Jones Received Received
  PO-068 The diagnostic yield of bone marrow biopsy in patients with liver failure Thinzar Ko Ko Received Received
  EP-068 Implementing Venetoclax treatment into Day Case setting for patients at High Risk of Tumour Lysis Syndrome; University Hospital Southampton NHS Foundation Trust experience Klara Matulay Received Received
  EP-069 18Fluoromethylcholine PET/CT: a new tool for CNS lymphoma Kirsty Marshall Received Received
  EP-070 Local experience of the use of IVE methotrexate chemotherapy for the treatment of systemic T cell lymphoma. Thomas Fail Received Received
  PO-071 The efficacy and predictive value of primary care two-week wait referrals for suspected haematological cancer: quality evaluation of GP referrals and their outcomes. Anmol Jaiswal Received Received
  PO-072 Symptom burden in Immune Thrombocytopenia (ITP): Findings reported by UK patients and physicians from the ITP World Impact Survey (I-WISh) Tom Bailey Received Received
  EP-072 Impact of Liso-cel Treatment on Health-Related Quality of Life and Health Utility in Patients With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin Lymphoma: TRANSCEND NHL 001 Donald Patrick Received Received
  PO-073 The clinical characteristics, Diagnosis and Management of patients with Mastocytosis in a Tertiary Centre Katie Hoyles Received Received
  PO-074 An evaluation of double or triple positivity in JAK2 positive Essential Thrombocythaemia and Primary Myelofibrosis Mohammed Khan Received Received
  EP-074 IS THE ALL-ORAL DEVEC METRONOMIC SCHEDULE A BETTER ALTERNATIVE TO INFUSIONAL CHEMOTHERAPY PROTOCOLS IN ELDERLY WITH PERIPHERAL T-CELL LYMPHOMA? M CHRISTINA COX Received Received
  PO-075 An audit of Tumour Lysis Syndrome prophylaxis in patients with haematological malignancies. Alexis Cairns Received Received
  PO-076 Establishing Haematology services in low income and low resource settings Experiences from Northern Tanzania steven leak Received Received
  EP-077 Anthracycline prescribing in Lymphoma: Traffic light guidance using NT-proBNP and echocardiogram Khaing Nyunt Received Received
  PO-077 Retrospective analysis of full blood counts and iron studies on patients diagnosed with bowel cancer. Toby Ball Received Received
  PO-078 Neutropenic Sepsis: Can We Do Better? Michael Caruana Dingli Received Received
  POA-079 UK Patient perceptions on the symptomatic and emotional burden of vaso-occlusive crises resulting from Sickle cell disease Tom Bailey Received Received
  EP-080 Palliative care needs during inpatient stay for commercial chimeric antigen receptor T-cell infusion at the Newcastle-Upon-Tyne Hospitals NHS Foundation Trust Katherine Smith Received Received
  EP-081 EPIDEMIOLOGY OF HAEMATOLOGICAL MALIGNANCIES IN NATIONAL HOSPITAL ABUJA: A TEN-YEAR RETROSPECTIVE STUDY Iniabasi Ekaete David Received Received
  PO-081 Updated Results of a Phase Ib/II Randomised Study: Polatuzumab Vedotin (Pola) Plus Bendamustine (B) and Rituximab (R) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Megan Fox Received Received
  EP-082 Experiences of providing commercial Chimeric Antigen Receptor (CAR-T) cell therapy at the Northern Centre for Cancer Care Katherine Smith Received Received
  EP-083 Btk Inhibitor Ibrutinib Impairs Fcγ947;RIIa-Mediated Responses of Platelets from Healthy Donors and Chronic Lymphocytic Leukaemia Patients to Bacteria. Leigh Naylor-Adamson Received Received
  PO-083 UK CLL Forum 5 year update on 315 relapsed refractory CLL patients treated with ibrutinib in 66 UK and Ireland centres George Follows Received Received
  EP-084 ACOPP Chemotherapy for Frontline Treatment of Older Patients with Hodgkin Lymphoma - a Pilot Study Matthew Wilson Received Received
  PO-085 Escalated BEACOPDac as first line therapy in 100 Hodgkin lymphoma patients reduces red cell transfusion requirements and may shorten time to menstrual period recovery whilst maintaining efficacy compared to escalated BEACOPP Anna Santarsieri Received Received
  PO-086 Addition of bendamustine to Brentuximab vedotin leads to improved complete metabolic remission rates in children, adolescents and young adults with relapsed and refractory classical Hodgkin lymphoma: a retrospective, single centre series Annabel McMillan Received Received
  EP-087 Outcomes of patients with refractory Peripheral T-cell lymphoma, Angioimmunblastic and other nodal lymphomas of T follicular helper-cell origin (OPerA) Waqas Jehangir Received Received
  EP-088 INCIDENCE OF CARDIOTOXICITY IN ANTRACYCLINE BASED CHEMOTHERAPY IN LYMPHOMA PATIENTS: A SINGLE CENTRE EXPERIENCE charlotte bloodworth Received Received
  PO-088 Adoption of rapid obinutuzumab infusions: real world experience Joel Cunningham Received Received
  EP-089 A single centre experience of using ciclosporin and mycophenolate mofetil immunosuppression in relapsed/refractory angio-immunoblastic T cell lymphoma. Kanchana De Abrew Received Received
  PO-089 Brentuximab vedotin plus chemotherapy for Stage III/IV classical Hodgkin lymphoma: 4-year update of the ECHELON-1 study Hedley Coppock Received Received
  EP-091 Treatment decisions in Waldenstroms Macroglobulinaemia; outcomes from the South East Scotland Cancer Network Alasdair Duguid Received Received
  PO-091 Systemic ALCL treated in routine clinical practice: survival outcomes following first-line chemotherapy from an international multicentre cohort study Martinez-Calle Nicolas Received Received
  EP-092 Safety, efficacy and tolerability of the NORDIC regimen in the front-line treatment of transplant-eligible patients with mantle cell lymphoma Jake Tobin Received Received
  PO-093 Finding the five percent: Predicting Adult T-cell Leukaemia/Lymphoma (ATLL) in Human T-cell leukaemia Virus-1 (HTLV-1) carriers using a novel flow cytometric method Sonia Wolf Received Received
  EP-094 Real World Outcomes for Treatment of Diffuse Large B cell Lymphoma in Patients aged 80 and over Rachel Cooke Received Received
  PO-096 Serial troponin measurement during anthracycline-containing chemotherapy may predict early cardiotoxicity that is amenable to primary prevention with ACE inhibitors Ipek Cakmak Received Received
  PO-098 Minimal Residual Disease and the Prediction of Survival Outcomes in Chronic Lymphocytic Leukaemia: A Pooled Analysis of Observational and Clinical Trial Data Charlotte Johnston Received Received
  PO-099 Incidence of BTK mutations in chronic lymphocytic leukaemia treated with BTK inhibitors in a single UK institution Elisa Santambrogio Received Received
  EP-101 Real world experience of KPD use in relapsed or refractory myeloma. Aisling Barrett Received Received
  PO-102 Modeling R-CHOP chemoimmunotherapy in murine lymphoma to characterize and overcome resistance Bernard Maybury Received Received
  EP-102 Mature osteoblasts induce myeloma cell death through inhibiting the Sp1-TAK1-Pim2-prosurvival Pathway Ariunzaya Bat-Erdene Received Received
  EP-103 Lenalidomide with Low-Dose Dexamethasone in Newly DiagnosedTransplant-Ineligible Myeloma. Real-World Experience: Data from a SingleCentre in North Wales, United Kingdom. Chaminda Arachchilage Received Received
  PO-103 Response to brentuximab vedotin plus CHP according to CD30 expression in the ECHELON-2 trial Hedley Coppock Received Received
  PO-104 IGHV Analysis Utilising the Ion GeneStudio S5 System and the Oncomine BCR IGH-LR Assay Early Access Experience Zadie Davis Received Received
  PO-105 Outcomes for Patients with Diffuse Large B Cell Lymphoma in the West of Scotland in the pre-CAR-T era Matthew Wilson Received Received
  EP-105 Use of imaging in the management of newly diagnosed patients with myeloma at St. Georges Hospital Ke Xu Received Received
  PO-106 Phase Ib/II Trial of Polatuzumab Vedotin Plus Obinutuzumab and Lenalidomide in Patients with Relapsed/Refractory Follicular Lymphoma: Primary Analysis of the Full Efficacy Population Megan Fox Received Received
  EP-106 Dynamic changes in serum complements during chemotherapy in patients with Multiple Myeloma and their correlations to disease markers Sateesh Kumar Nagumantry Received Received
  PO-107 Real world, multi-centre experience of daratumumab monotherapy and response to subsequent treatments in relapsed/refractory myeloma Jessica Taube Received Received
  EP-107 HaemBase Cymru (HBC): An electronic data collection platform for patients treated with haematological malignancies in Wales. Zeyad Khalaf Received Received
  PO-108 Myeloma: not just bones at risk of fracture assessing the increasing demand on services Tanya Freeman Received Received
  EP-109 Lenalodamide Induced ITP in myeloma patients with response to steroid and TPO agents - A rare but important event to consider- case series from single institute from south India Nishith Vaddeboina Received Received
  PO-109 Real world outcomes in multiple myeloma in patients aged 75 and over David Hopkins Received Received
  EP-110 A Retrospective Review of Antimicrobial Use and Risk Stratification of Patients with Multiple Myeloma Admitted Due to Suspected Infection Suzanne Raffles Received Received
  EP-111 Myeloma in Northland 2016-2017: incidence, risk factors and outcome Kevin Breen Received Received
  EP-114 Osteonecrosis of the jaw secondary to bisphosphonate treatment in multiple myeloma - Real world data. Lewis Vanhinsbergh Received Received
  EP-118 Incorrect specimen collection for investigation of cryoproteins can give mis-leading results Rachel Wheeler Received Received
  PO-118 Impact of Change of Mobilisation Method on Adequacy of Stem Cell Collection in Multiple Myeloma Patients Single Centre Experience Valarmathi Valarmathi Received Received
  EP-119 Implementing a remote monitoring clinic for patients with stage A CLL Rebecca Bowen Received Received
  EP-120 Audit of invasive fungal disease (IFD) in paediatric haematopoietic stem cell transplant (HSCT) recipients and compliance with a national guideline for the diagnosis, prevention and treatment of fungal infections during paediatric HSCT; the Royal Marsden Olga Tatarinova Received Received
  PO-120 A Single Centre Review of Bortezomib Home-administration in Myeloma Patients: Portsmouth Experience Kanchana De Abrew Received Received
  EP-121 Predicting treatment response in paediatric chronic ITP patients Shonnelly Novintan Received Received
  PO-121 End of Life Management of Patients with Myeloma at University Hospitals Birmingham Beena Salhan Received Received
  EP-122 Growth velocity in children with sickle cell disease is increased or maintained whilst taking Hydroxycarbamide . Amrana Qureshi Received Received
  PO-123 Prevention and management of steroid-induced hyperglycaemia in outpatient myeloma chemotherapy - a tertiary centre audit and quality improvement project. Pietro Vassallo Received Received
  EP-124 Hydroxycarbamide: clinically effective, but parents still delay starting. Oyinkansola Oremakinde Received Received
  PO-125 Efficacy of Daratumumab Combination Regimen in Patients with Multiple Myeloma: A Combined Analysis of Six Phase III Randomised Controlled Trials THURA HTUT Received Received
  EP-125 Help me Grow A Quality Improvement Project on Neonatal Blood Transfusion Ai Ling Tan Received Received
  EP-126 Impact of changing from co-trimoxazole to alternative pneumocystis pneumonia prophylaxis on the intensity of maintenance chemotherapy in the treatment of children with Acute Lymphoblastic Leukaemia Susan Baird Received Received
  PO-126 A Narrative Inquiry into Patients Experience of Receiving Blood Transfusions in a Day Unit Setting whilst in a Palliative Stage of a Haematological Malignancy. Laraine Lloyd Received Received
  PO-127 Improving Haematology Clinics: Chesterfield Royal Hospital experience Rowena Faukner Received Received
  EP-127 Management of Life-Threatening Haemolytic Anaemia in an Adolescent Jehovahs Witness Rosina Shujaat Received Received
  PO-128 A survey on relevance of blood test before Bortezomib in Myeloma patients in Leicester Royal Infirmary Jennifer Tam Received Received
  PO-129 Pilot Initiative on Buddy Scheme in Chesterfield Royal Hospital Jennifer Tam Received Received
  EP-129 Anaemia and its correlates in HAART-Nave patients in Port Harcourt, Nigeria Hannah Omunakwe Received Received
  EP-130 Sickle Cell Disease Pain Management in the Emergency Department: a single centre experience Jonathan Massie Received Received
  PO-130 Optimising services by offering care closer to home: The introduction of telephone consultations for patients on treatment for liver Graft vs Host Disease Laura Ricketts Received Received
  PO-131 Rolling out adult and paediatric, patient centred Emicizumab education, counselling and administration training: Experience from a Haemophilia commissioned network covering a large catchment area Udaya Reddy Received Received
  EP-131 An Investigation into the presence of complement factors on erythrocyte vesicles in sickle cell disease Chidinma Obieze Received Received
  PO-132 Implementing a Venetoclax nursing care plan for a safe administration in a Haematology setting. Rebecca Bowen Received Received
  EP-133 Characteristics of menstruation in sickle cell disease patients attending a tertiary health care centre in Northern Nigeria Aisha Abba Received Received
  PO-133 Becoming a nurse Principal Investigator Emma Williams Received Received
  PO-134 An eight week pilot of a weekly Haematology Day Unit Information Evening event charlotte bloodworth Received Received
  EP-135 FREQUENCY OF ANEMIA AND CAUSES IN POST LIVER TRANSPLANT PATIENTS FROM TERTIARY CARE HOSPITAL IN PAKISTAN: A RETROSPECTIVE AUDIT Samreen Khan Received Received
  PO-136 Capillary blood sampling for anti-Xa monitoring in paediatric patients- A practice changing quality improvement project at Birmingham Childrens Hospital Claire Horgan Received Received
  EP-136 Evaluation Of High Performance Liquid Chromatography Pattern And Prevalence Of Thalassemia Trait In Port Harcourt, Nigeria Hannah Omunakwe Received Received
  PO-137 Significant levels of endogenous formaldehyde in humans a potential driver of Fanconi anaemia? Luke Glover Received Received
  EP-138 The Successful use of Eculizumab to Switch off Haemolysis in Aggressive warm IgM Autoimmune Haemolytic Anaemia: Case Report and Literature Review Mohammed Altohami Received Received
  PO-138 Intensive Care Admissions For Children With Acute Lymphoblastic Leukaemia: A 13 year single centre experience Melpomeni Rompola Received Received
  EP-139 Discrepant interpretation of HIT screening results on the same sample - data from a UK NEQAS for Blood Coagulation exercise. Ian Jennings Received Received
  PO-139 TRANSCRANIAL DOPPLER SCREENING PROGRAMME IN CHILDREN AND ADOLESCENTS WITH SICKLE CELL DISEASE: EXPERIENCE IN A DISTRICT GENERAL HOSPITAL IN THE UK. Amrana Qureshi Received Received
  EP-140 Pre - analytical variables in haemostasis: Results of the UK National External Quality Assessment Scheme for Blood Coagulation haemolysis supplementary exercise. Lilia Brown Received Received
  EP-141 Effects of Rivaroxaban on thrombophilia screening tests results from a UK NEQAS (Blood Coagulation) Exercise Ian Jennings Received Received
  EP-142 Management of pregnancy-associated acquired haemophilia A: a case-series from the Oxford Haemophilia and Thrombosis Centre, UK Ayesha Ejaz Received Received
  PO-143 Effects of luspatercept on iron overload and impact on responders to luspatercept: results from the BELIEVE trial Jennifer Mark Received Received
  PO-145 One-Year Efficacy of Ravulizumab (ALXN1210) in Adult Patients with Paroxysmal Nocturnal Haemoglobinuria Naive to Complement Inhibitors nira dass Received Received
  PO-146 One-Year Efficacy and Safety from a Phase 3 Trial of Ravulizumab in Adult Patients with Paroxysmal Nocturnal Haemoglobinuria Receiving Prior Eculizumab Treatment nira dass Received Received
  PO-147 Assessment of longer-term efficacy, safety, and haematological improvement in the phase 3, randomised, double-blind, placebo-controlled MEDALIST trial of luspatercept to treat anaemia in patients with lower-risk myelodysplastic syndromes with ring sideroblasts who require red blood cell transfusions Jennifer Mark Received Received
  PO-148 Evaluating luspatercept responders in the phase 3, randomised, double-blind, placebo-controlled BELIEVE trial of luspatercept in adult beta-thalassaemia patients who require regular red blood cell transfusions Jennifer Mark Received Received
  EP-148 A Systematic Review and Meta- Analysis of Randomized Controlled Trials on Primary Ambulatory Thromboprophylaxis (PATP) in Patients with Ovarian Cancer Receiving Chemotherapy THURA HTUT Received Received
  PO-149 Unilateral Versus Bilateral Peripheral Access Using Ultrasound Machine Guidance in Patients Undergoing Red Blood Cell Exchange Transfusion: A Comparative Results Romeo Valeza Received Received
  PO-150 Breakthrough Haemolysis in Adult Patients with Paroxysmal Nocturnal Haemoglobinuria Treated with Ravulizumab: Results of a 52-Week Extension from Two Phase 3 Studies. nira dass Received Received
  PO-151 Patient Preferences for the Treatment of Paroxysmal Nocturnal Hemoglobinuria: Results of a Patient Survey of Ravulizumab (ALXN1210) and Eculizumab in the UK nira dass Received Received
  EP-151 Clinical Characteristics and Outcomes in Patients Treated with Eculizumab for Suspected Atypical Haemolytic Uraemic Syndrome (aHUS) - A Single Tertiary Centre Experience Matthew Alley Received Received
  EP-152 Do patients taking Direct Oral Anticoagulants (DOAC) require regular systematic review? Evidence from a Comprehensive Anticoagulation and Thrombosis Centre Nausheen Kamran Received Received
  EP-153 Venous Thromboembolism in a large teaching hospital over the last 10 years: changing patterns of disease Huw Rowswell Received Received
  PO-153 Association Between Protein C, Protein S and Cerebral Blood Flow Velocity in Sickle Cell Disease Patients with High Risk of Cerebrovascular Accident Ebele Uche Received Received
  EP-155 Patients with acute Thrombotic Thrombocytopenic Purpura (TTP) should be managed in a Critical Care Setting A Single TTP Referral Centre Experience Rebecca Jane Shaw Received Received
  EP-156 Why do we use warfarin today? A retrospective study from a large comprehensive anticoagulation centre. Kumari Perera Received Received
  PO-156 Haemoglobin Distribution Width is Low in Alcoholic Liver Disease Graham Gibbs Received Received
  EP-158 Clinical Outcomes from Lupus Anticoagulant Testing Sarrah Tayabali Received Received
  PO-159 Improving the Laboratory Diagnosis of Pyruvate Kinase Deficiency Claire Laas Received Received
  EP-159 ISTH SSC plasma standard lot 5 results in a UK National External Quality Assessment Scheme for Blood Coagulation exercise Ian Jennings Received Received
  PO-160 Luspatercept significantly reduces red blood cell transfusion burden, regardless of gene mutation frequency, spectrum, and prognostic significance, among patients with lower-risk myelodysplastic syndromes enrolled in the MEDALIST trial Jennifer Mark Received Received
  EP-161 Fixed dose prothrombin complex concentrate for direct oral anticoagulant and warfarin reversal: a rapid and effective solution Jennifer Davies Received Received
  PO-161 Bone And Joint Health Markers In Persons With Haemophilia A (PwHA) Treated With Emicizumab In HAVEN 3 Anna Kiialainen Received Received
  PO-164 Platelet storage pool disease with excessive bleeding associated with a novel FLI1 variant. PATRICIA BIGNELL Received Received
  EP-164 Patients with below knee DVT are at risk of both under and over- treatment: results from a retrospective review of cases identified at University Hospitals Bristol Sarah Westbury Received Received
  EP-165 A retrospective review of suspected thrombotic thrombocytopenic purpura cases from a tertiary referral centre Amy Knott Received Received
  PO-165 Shear flow-based assay with HUVECs shows von Willebrand Factor (VWF) strings anchored to the endothelial surface and platelet aggregation in acute immune-mediated Thrombotic Thrombocytopenic Purpura. Chiara Vendramin Received Received
  EP-166 Approach to manage thrombotic events while on Anti coagulation Lovina Thomas Received Received
  EP-167 Heparin-induced thrombocytopaenia (HIT): an audit of the diagnostic pathway at Barts Health NHS Trust Martin Haywood Received Received
  PO-168 Factor VIII levels and bleeding according to factor 8 mutation in pregnant carriers of haemophilia A: a multi-centre retrospective cohort study Annie Collins Received Received
  EP-169 Monitoring direct oral anticoagulant plasma concentrations experience from the Princess Royal University Hospital Rachna Patel Received Received
  EP-170 Overview of Clinical characteristics of patients with TTP (Thrombotic Thrombocytopenic Purpura) in a low socio-economic population in New York: A 6-year center experience. Preethi Ramachandran Received Received
  PO-171 A Systematic Review of Efficacy and Safety of Chemical Thromboprophylaxis in Renal Transplantation Ruchika Kohli Received Received
  EP-171 Comparing Patient Experience and Adherence with Rivaroxaban or Warfarin (PACT); Well, you know it (warfarin) kills rats, whats it doing to me? Dan Sly Received Received
  EP-173 A Retrospective Audit of Perioperative Management of Anaemia in Patients Undergoing Elective Primary Total Hip Replacement in a District General Hospital Nitesh Rathod Received Received
  PO-173 UK NEQAS for Blood Coagulation D-dimer Point of care testing programme Dianne Patricia Kitchen Received Received
  EP-174 Blood donation deferral pattern in a low income blood banking service Mutiat Ogunfemi Received Received
  PO-174 Observational study of outcomes in patients with antiphospholipid syndrome anticoagulated with Rivaroxaban THURA HTUT Received Received
  EP-175 Awareness and attitudes towards voluntary non-remunerated blood donation in two generational groups in Trinidad and Tobago kenneth charles Received Received
  PO-175 External Quality Assurance (EQA) for the Thromboelastometry devices: UK NEQAS BC programme update Dianne Patricia Kitchen Received Received
  EP-176 Blood loss, cell salvage, tranexamic acid and transfusion: an audit of major surgery at a tertiary hospital Sarah Dawson Received Received
  PO-177 The differential surface expression of tissue factor between monocyte subsets Kathryn Musgrave Received Received
  EP-177 The impact of anticoagulation and perioperative blood transfusion in fragility hip fracture patients. Michael Greenhalgh Received Received
  EP-178 An audit of cell free foetal DNA (cffDNA) screen to avoid administration of anti-D immunoglobulin in RHD negative pregnant women with RHD negative foetus. Kamala Gurung Received Received
  PO-179 Anticoagulation In Palliative And End Of Life Care - Results Of A Supra-Regional Audit And Literature Review Kat Moss Received Received
  EP-179 The Consultant Clinical Scientist in Transfusion - Overview and Reflections on the Journey to FRCPath Tom Bullock Received Received
  PO-180 The CAVEaT multicentre audit of venous thrombosis in patients with haematolical malignancy and thrombocytopenia: preliminary results. Stephen Booth Received Received
  PO-181 Dynamic and Time-To-Event Analyses Demonstrate Marked Reduction in Transfusion Requirements for Janus Kinase InhibitorNave Myelofibrosis Patients Treated with Momelotinib Compared Head to Head with Ruxolitinib Andrew Dye Received Received
  EP-181 Detection of red cell antibodies in patient plasma after 3 months storage above the recommended -30C Kara Manning Received Received
  PO-182 Title: A simulation study of pre-hospital whole blood transfusion: what are the benefits? Harriet Tucker Received Received
  PO-183 A Feasibility Study on the Provision of Extended Matched Red Cells for Transfusion Support in Chronic Haematological Diseases Sarah Henton Received Received
  EP-183 Intra-operative Blood Utilization and Wastage in a Low Resource Tertiary Hospital in Northern Nigeria Saidu Yakubu Received Received
  EP-184 Cross-Trust Mandatory Training in Transfusion Charlene Furtado Received Received
  PO-184 Rh antibodies in patients with sickle cell disease an on-going challenge Catherine Booth Received Received
  PO-185 Group O D Negative Blood Promoting the appropriate use of an essential but limited resource Shubha Allard Received Received
  EP-186 How Do They Measure Bleeding? Analyzing the Triggers Applied by the Obstetric Specialists for Initiating Blood Transfusion for Postpartum Haemorrhage Mathurange Krishnapillai Received Received
  PO-186 Does Early Discharge Affect Administration Of Anti-D Ig Prophylaxis Victoria Tuckley Received Received
  EP-187 Evaluation of Preoperative Haemoglobin Level and Blood TransfusionPractices among Patients Attending to a Tertiary care unit in Sri Lanka -Colombo North Teaching Hospital Pabasara Premarathne Received Received
  PO-188 Reduction of Platelet Thresholds to Adhere with British Society of Haematology (BSH) Guidance for Tunnelled Central Line Insertion does not Increase Bleeding Complication in Haematology Patients; a Single Centre Experience Luke Carter-Brzezinski Received Received
  EP-188 Blood Transfusion Refusers: A Clinical Audit About Referrals and Their Outcome Naomi Melamed Received Received
  EP-189 Does measuring ferritin in the first or third trimester, optimise diagnosis of obstetric iron deficiency anaemia, thereby leading to prompt oral iron therapy and a reduction in blood transfusions? Andreea Neamtiu Received Received
  PO-190 Incorrect Plasma Components Transfused: When It Comes To ABO Compatibility Do We Need To Stop Only Ever Seeing Red? Victoria Tuckley Received Received
  EP-190 An insight into the knowledge, attitude and practice towards blood donation among the students, health workers and general population of Hyderabad Sindh. NAZIA HAFEEZ Received Received
  EP-191 An Audit of Out-of-Hours Transfusions Across Two Hospital Sites Catherine Booth Received Received
  PO-191 Transfusion 2024 defining a 5-year national strategy for clinical and laboratory transfusion practice Shubha Allard Received Received
  PO-192 Patient identification errors in transfusion continue to compromise patient safety Victoria Tuckley Received Received
  EP-192 High Prevalence of Haemolytic Antibodies: a Challenge for Safe Blood Transfusion in Africa Ifeyinwa Okafor Received Received
  PO-194 Red blood cell antibodies and adverse transfusion events in multi-transfused patients with sickle cell disease in Ghana Lilian Antwi Boateng Received Received
  PO-195 Transfusion in iron deficiency anaemia: retrospective audit of the frequency and nature of transfusion in the context of iron deficiency in Scottish hospital Sarah Beverstock Received Received
  PO-196 Avoidable Red cell transfusion due to Inadequate Investigation of Anaemia (ARIIA): A national study to determine if the patients that were transfused in an acute care setting were appropriately investigated for the causes of the anaemia Alexandros Rampotas Received Received
  EP-196 Autologous stem cell transplantation for ed myeloma patients aged 70 years is safe and effective and similar to that of younger patients: a single centre experience Anne Fenech Received Received
  PO-197 Impact of Fetal RHD screening upon a UK hospitals practice for Routine Antenatal Anti-D Prophylaxis (RAADP) Anna Li Received Received
  EP-197 Lung function screening following allogeneic haematopoietic stem cell transplantation Callum Wright Received Received
  EP-198 Abatacept acute graft versus host disease prophylaxis is feasible and safe when combined with post transplant cyclophosphamide in the mobilised peripheral blood haplo-identical donor setting. Jun Yong Received Received
  PO-198 What Do They Know and What Should We Tell Them- Knowledge, Attitude and Education on Blood Transfusion Therapy Among Antenatal Mothers Mathurange Krishnapillai Received Received
  EP-200 Feasibility, safety, and efficacy of Abatacept for steroid refractory acute graft versus host disease. Jun Yong Received Received
  PO-200 Audit of red cell genotyping in sickle cell disease patients in two London trusts Yee Man Tracy Hui Received Received
  EP-201 The Use of Artificial Nutritional Support within a National Allogeneic Transplant Unit Abigail Dean Received Received
  PO-202 Prophylactic donor lymphocyte infusion reduces the risk of relapse and increases survival in patients with mixed T cell chimerism after reduced intensity allogeneic stem cell transplantation Richard Buka Received Received
  EP-203 The Treatment of Late-onset Hepatic Veno-occlusive Disease Following Hematopoietic Stem Cell Transplantation Using Defibrotide: a Case Study. Marie Waller Received Received
  PO-203 Defibrotide treatment for veno-occlusive disease/sinusoidal obstruction syndrome after haematopoietic cell transplantation: outcomes by severity and multi-organ failure status in an observational registry study Lawson Nyce Received Received
  PO-204 Outcomes of Allografts for Acute Myeloid Leukaemia and Myelodysplastic Syndromes in Patients Aged over 60 years and over 65 years are not inferior to those of younger patients: a single centre study Jennifer Byrne Received Received
  EP-204 Vyxeos in high risk MDS as induction therapy prior to stem cell transplantation Amanda Swan Received Received
  PO-205 The use of Autologous Haematopoietic Stem Cell Transplants in patients with Relapsing Remitting Multiple Sclerosis: A Meta-Analysis Owain Greaves Received Received
  PO-207 First report of post-transplant autoimmune hyperlipidaemia and treatment with rituximab Wing Yee Sin Received Received
  PO-208 Reduced Intensity Conditioning with Thiotepa-Fludarabine-Busulphan (TBF) and Post-Transplant Cyclophosphamide (PTC) Results in Rapid Complete Donor T-cell Chimerism in Haploidentical Recipients with Acute Myeloid Leukaemia Rishi Banerjee Received Received
Tel.: +34 91 736 2385
LOCAL TIME
Contact: Cristina Miralles
Hours: Mon-Fri 8:30-15:00
06:11
For help with a poster, please specify the poster number, the first author and the congress and we will reply shortly.
Poster no.
Contact name
E-mail
Telephone
Congress
Comments
Captcha image
 

BRITISH SOCIETY FOR HAEMATOLOGY

BSH 2020 VIRTUAL

 

9-14 November 2020 Virtual Conference
HELP LINE
Manage Orders
FAQs
Virtual Poster Gallery
Search and consult posters online
in an exclusive section
for each poster
    ACTIVE FROM 30/10/2020 TO 09/11/2021
Poster
Gallery
Oral Presentation
& Video Gallery
Poster Discussion
Forum
                  
PrintingOnline
Submit your poster online
in powerpoint format

   Poster submission deadline 02/11/2020
Upload Poster
Upload Oral Presentation of Video
Upload
Poster
Upload Oral
Presentation or Video




PosterSessionOnline
Logo Draft
 
Logo Cert